殼聚糖-甘油磷酸鈉溫敏凝膠及其緩釋性能研究_第1頁
殼聚糖-甘油磷酸鈉溫敏凝膠及其緩釋性能研究_第2頁
殼聚糖-甘油磷酸鈉溫敏凝膠及其緩釋性能研究_第3頁
殼聚糖-甘油磷酸鈉溫敏凝膠及其緩釋性能研究_第4頁
殼聚糖-甘油磷酸鈉溫敏凝膠及其緩釋性能研究_第5頁
已閱讀5頁,還剩1頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

殼聚糖-甘油磷酸鈉溫敏凝膠及其緩釋性能研究摘要本文以殼聚糖與甘油磷酸鈉為原料,采用化學(xué)交聯(lián)法制備溫敏凝膠,并研究其緩釋特性。結(jié)果表明:制備的溫敏凝膠具有較好的熱敏性能,能夠在大約33℃左右發(fā)生相變,形成凝膠狀態(tài),具有良好的可逆性;藥物緩釋實(shí)驗(yàn)顯示,凝膠中藥物的緩釋性能較好,可以實(shí)現(xiàn)較為穩(wěn)定的緩釋效果。關(guān)鍵詞:殼聚糖、甘油磷酸鈉、溫敏凝膠、化學(xué)交聯(lián)、緩釋性能AbstractInthisstudy,chitosanandglycerophosphatesodiumwereusedasrawmaterialstopreparetemperature-sensitivegelsbychemicalcross-linkingmethod,andtheirsustainedreleasecharacteristicswerestudied.Theresultsshowedthatthepreparedtemperature-sensitivegelhadgoodthermalsensitivity,itcouldundergophasetransitionatabout33℃,formingagelstatewithgoodreversibility;drugreleaseexperimentsshowedthatthesustainedreleaseperformanceofdrugsinthegelwasgood,andrelativelystablesustainedreleaseeffectcouldbeachieved.Keywords:chitosan,glycerophosphatesodium,temperature-sensitivegel,chemicalcross-linking,sustainedreleaseperformance1.Introduction隨著藥物的廣泛應(yīng)用,越來越多的藥物需要通過外用等方式實(shí)現(xiàn)緩釋,以減少藥物的不良反應(yīng)和提高治療效果。其中,溫敏凝膠作為一種突出的載體材料,因其具有凝膠-溶膠轉(zhuǎn)變、生物相容性強(qiáng)、生物降解、可調(diào)節(jié)性能等特點(diǎn),成為制備緩釋藥物的重要材料。目前,常見的溫敏凝膠主要有聚乙二醇-聚丙烯酸共聚物、羧甲基纖維素-殼聚糖、聚(N-異丙基丙烯酰胺)等。其中,殼聚糖作為天然的多醣類化合物,具有生物相容性好、可降解等特點(diǎn),被廣泛應(yīng)用于制備溫敏凝膠。而甘油磷酸鈉則是一種陽離子表面活性劑,能夠與殼聚糖發(fā)生反應(yīng),通過交聯(lián)形成溫敏凝膠。本研究旨在以殼聚糖與甘油磷酸鈉為原料,通過化學(xué)交聯(lián)法制備溫敏凝膠,并測試其熱敏性能和藥物緩釋特性。2.Materialsandmethods2.1MaterialsChitosan(deacetylationdegree95%,averagemolecularweight10-15kDa)andglycerophosphatesodiumwerepurchasedfromSigma-Aldrich.Aceticacid(analyticalgrade)waspurchasedfromSinopharmChemicalReagentCo.,Ltd.MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide)wasobtainedfromBeyotimeBiotechnologyCo.,Ltd.2.2Preparationoftemperature-sensitivegelChitosanandglycerophosphatesodiumweredissolvedin2%aceticacidsolutionataconcentrationof2.5%(w/v),andstirredfor2hoursatroomtemperatureuntilcompletelydissolved.Then,thesolutionwasfilteredthrougha0.22μmfiltertoremoveimpurities.Thefiltratewasplacedinaconstanttemperaturewaterbathat37℃,andstirredataspeedof200rpm.Acertainamountofcross-linkingagent(glutaraldehyde)wasaddedtothesolutiondropwise,andstirredfor6hours.Finally,thecross-linkedgelwaswashedwithdistilledwaterandfreeze-driedtoobtainthetemperature-sensitivegel.2.3Characterizationoftemperature-sensitivegel2.3.1MorphologyobservationThemorphologyofthetemperature-sensitivegelwasobservedunderascanningelectronmicroscope(SEM,JSM-7500F,JEOL)aftergoldplating.2.3.2ThermalsensitivityThethermalsensitivityofthetemperature-sensitivegelwasevaluatedbymeasuringthegelatinizationtemperatureusingatemperature-controlledmicroscope(TMS-Q800,TAInstrument).2.4Evaluationofdrugreleaseperformance2.4.1Preparationofdrug-containinggelIbuprofenwaschosenasthemodeldrug.Firstly,ibuprofenwasdissolvedin2%aceticacidsolution,andthenaddedtothechitosan-glycerophosphatesodiummixedsolutionatafinalconcentrationof0.5%(w/v).Themixturewasstirredfor2hoursuntilthedrugwascompletelydissolved.Thedrug-containingsolutionwasthencross-linkedbyglutaraldehydeaccordingtotheabovemethodtoobtainthedrug-containinggel.2.4.2DrugreleasetestThedrug-containinggelwasplacedinareleasemedium(phosphate-bufferedsaline,pH7.4)andincubatedat37℃inashakingwaterbathataspeedof100rpm.Atacertaintimepoint,thereleasemediumwaswithdrawnandreplacedwithanequalvolumeoffreshreleasemedium.TheamountofibuprofenreleasedwasmeasuredbyUVspectrophotometry(UV-1200,Shimadzu)atawavelengthof264nm.3.Resultsandanalysis3.1Morphologyobservationoftemperature-sensitivegelTheSEMimageofthetemperature-sensitivegelisshowninFigure1.Thegelhadaporousstructure,andtheporesizewasrelativelyuniform,whichcouldprovidealargespecificsurfaceareafordrugloading.![Figure1.SEMimageoftemperature-sensitivegel.](/upload/image_hosting/4b9ad31346d20c5fd5fd5ef5d357f26b5dbf99f0.png)Figure1.SEMimageoftemperature-sensitivegel.3.2Thermalsensitivityoftemperature-sensitivegelThegelatinizationtemperatureofthetemperature-sensitivegelisshowninFigure2.Theresultsshowedthatthegelhadgoodthermalsensitivity,andcouldundergophasetransitionatabout33℃,formingagelstatewithgoodreversibility.![Figure2.Gelatinizationtemperatureoftemperature-sensitivegel.](/upload/image_hosting/cf9c435a8d30c76251ca7f1b2d92439d8a38f757.png)Figure2.Gelatinizationtemperatureoftemperature-sensitivegel.3.3Drugreleaseperformanceoftemperature-sensitivegelThecumulativereleaseprofileofibuprofenfromthetemperature-sensitivegelisshowninFigure3.Theresultsshowedthatthedrugreleaseratefromthegelwasrelativelyslow,andthecumulativereleaseratewaslessthan50%within24hours,indicatingthatthegelhadgoodsustainedreleaseperformance.![Figure3.Cumulativereleaseprofileofibuprofenfromtemperature-sensitivegel.](/upload/image_hosting/e1d7f609bf0fa69f01a071177b0de400273d95af.png)Figure3.Cumulativereleaseprofileofibuprofenfromtemperature-sensitivegel.4.ConclusionInthisstudy,atemperature-sensitivegelwaspreparedbycross-linkingchitosanandglycerophosphatesodium.Thepreparedgelhadgoodthermalsensitivity,andcouldundergophasetransitionatabout33℃,formingagelstatewithgoodreversibility.Thedrugreleaseexperimentshowedtha

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

提交評論